A detailed history of Strategy Asset Managers LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Strategy Asset Managers LLC holds 57,484 shares of JNJ stock, worth $8.91 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
57,484
Previous 61,673 6.79%
Holding current value
$8.91 Million
Previous $9.01 Million 3.34%
% of portfolio
1.8%
Previous 1.78%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$145.48 - $167.38 $609,415 - $701,154
-4,189 Reduced 6.79%
57,484 $9.32 Million
Q2 2024

Aug 02, 2024

BUY
$144.38 - $157.78 $380,008 - $415,276
2,632 Added 4.46%
61,673 $9.01 Million
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $48,583 - $50,937
-313 Reduced 0.53%
59,041 $9.34 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $54,163 - $59,103
372 Added 0.63%
59,354 $9.3 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $419,123 - $469,525
-2,691 Reduced 4.36%
58,982 $9.19 Million
Q2 2023

Aug 24, 2023

SELL
$154.35 - $166.11 $3,704 - $3,986
-24 Reduced 0.04%
61,673 $10.2 Million
Q1 2023

May 02, 2023

BUY
$151.05 - $180.26 $85,192 - $101,666
564 Added 0.92%
61,697 $9.56 Million
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $227,644 - $255,481
1,421 Added 2.38%
61,133 $10.8 Million
Q3 2022

Oct 11, 2022

BUY
$161.33 - $179.52 $201,178 - $223,861
1,247 Added 2.13%
59,712 $9.75 Million
Q2 2022

Jul 13, 2022

SELL
$168.19 - $186.01 $178,617 - $197,542
-1,062 Reduced 1.78%
58,465 $10.4 Million
Q1 2022

Apr 11, 2022

BUY
$158.14 - $179.59 $503,517 - $571,814
3,184 Added 5.65%
59,527 $10.6 Million
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $199,122 - $220,933
-1,277 Reduced 2.22%
56,343 $9.64 Million
Q3 2021

Dec 14, 2021

SELL
$161.5 - $179.47 $725,135 - $805,820
-4,490 Reduced 7.23%
57,620 $9.31 Million
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $73,679 - $79,034
462 Added 0.75%
62,110 $10.2 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $284,250 - $316,581
-1,857 Reduced 2.92%
61,648 $10.1 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $207,995 - $238,745
-1,517 Reduced 2.33%
63,505 $10 Million
Q3 2020

Nov 03, 2020

SELL
$140.38 - $153.83 $459,182 - $503,177
-3,271 Reduced 4.79%
65,022 $9.68 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $221,810 - $267,788
-1,722 Reduced 2.46%
68,293 $9.6 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $477,012 - $660,925
-4,292 Reduced 5.78%
70,015 $9.18 Million
Q4 2019

Feb 13, 2020

SELL
$127.5 - $146.44 $390,150 - $448,106
-3,060 Reduced 3.96%
74,307 $10.8 Million
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $269,768 - $302,047
-2,125 Reduced 2.67%
77,367 $10 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $451,942 - $497,051
-3,446 Reduced 4.15%
79,492 $11.1 Million
Q1 2019

May 08, 2019

SELL
$125.72 - $139.79 $170,602 - $189,695
-1,357 Reduced 1.61%
82,938 $11.6 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $368,520 - $443,520
-3,000 Reduced 3.44%
84,295 $10.9 Million
Q3 2018

Nov 01, 2018

SELL
$121.58 - $142.88 $112,704 - $132,449
-927 Reduced 1.05%
87,295 $0
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $25,671 - $28,328
-215 Reduced 0.24%
88,222 $10.7 Million
Q1 2018

May 03, 2018

SELL
$125.1 - $148.14 $239,316 - $283,391
-1,913 Reduced 2.12%
88,437 $11.3 Million
Q4 2017

Jan 29, 2018

SELL
$131.22 - $143.62 $260,865 - $285,516
-1,988 Reduced 2.15%
90,350 $12.6 Million
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $364,846 - $381,500
2,818 Added 3.15%
92,338 $12 Million
Q2 2017

Aug 07, 2017

BUY
N/A
89,520
89,520 $11.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.